Evaluating the efficacy and safety of MDMA for the treatment of Post Traumatic Stress Disorder: a systematic review
| dc.contributor.author | Kodancha, Megha | en |
| dc.contributor.author | Chahrour, Houssein | en |
| dc.contributor.author | Carey, Cassandra | en |
| dc.contributor.author | Fazeli, Hiva | en |
| dc.contributor.author | Azadian, Anahita | en |
| dc.contributor.author | Kajitani, Sten Hiroshi | en |
| dc.contributor.editor | Mehta, Shobha | en |
| dc.contributor.editor | Cronin, Pádraig | en |
| dc.date.accessioned | 2025-10-28T13:54:55Z | |
| dc.date.available | 2025-10-28T13:54:55Z | |
| dc.date.issued | 2025 | en |
| dc.description.abstract | Background: Posttraumatic stress disorder (PTSD) affects approximately 5-7% of the population, with conventional treatments often proving inadequate for some patients. Recent studies suggest that methylenedioxymethamphetamine (MDMA) combined with psychotherapy may offer a novel therapeutic approach. This systematic review evaluates the efficacy and safety of MDMA-assisted psychotherapy for the treatment of PTSD in individuals with chronic, treatment-resistant forms of the disorder. Methods: A comprehensive search was conducted in PubMed, OVID, Scopus, Cochrane databases, and select reference lists for randomized controlled trials (RCTs) evaluating MDMA as a treatment for PTSD. Eligibility criteria included RCTs with participants with confirmed PTSD diagnoses using standardized clinical assessments. Results: In the RCT studies, there are significant reductions in PTSD symptoms (p<0.05) in those with MDMA-assisted psychotherapy compared to those with placebo and psychotherapy; dose-dependent improvements were observed in various measurements scales (specifically in CAPS-IV/CAPS-5 scores). Open-label trials further demonstrated improvements in PTSD symptoms when given MDMA-assisted therapy (p<0.05) and long-term analyses of studies demonstrated that effects of MDMA-assisted therapy were maintained for a minimum of 12 months post-intervention(p<0.05). Adverse effects were transient and mild to moderate, including anxiety, headache, fatigue, muscle tension, and insomnia. Conclusion: Extant data suggests that MDMA-assisted psychotherapy for PTSD demonstrates significant symptom reduction, with sustained efficacy up to 12 months post-treatment. Functional unblinding is a major methodological challenge, which makes it difficult to interpret the magnitude of the effect MDMA has in the treatment of treatment-resistant PTSD. Future research should refine methodologies and explore long-term safety and efficacy in diverse populations. | en |
| dc.description.status | Peer reviewed | en |
| dc.description.version | Published Version | en |
| dc.format.mimetype | application/pdf | en |
| dc.identifier.citation | Kodancha, M., Chahrour, H., Carey, C., Fazeli, H., Azadian, A. and Kajitani, S. H. (2025) 'Evaluating the efficacy and safety of MDMA for the treatment of Post Traumatic Stress Disorder: a systematic review', UCC Student Medical Journal, 5, pp.28-37. https://doi.org/10.33178/SMJ.2025.1.4 | en |
| dc.identifier.doi | 10.33178/SMJ.2025.1.4 | en |
| dc.identifier.endpage | 37 | en |
| dc.identifier.issn | 2737-7237 | |
| dc.identifier.journalabbrev | UCC SMJ | |
| dc.identifier.journaltitle | UCC Student Medical Journal | en |
| dc.identifier.startpage | 28 | en |
| dc.identifier.uri | https://hdl.handle.net/10468/18081 | |
| dc.identifier.volume | 5 | |
| dc.language.iso | en | en |
| dc.publisher | UCC Medical Research and Technology Society | en |
| dc.rights | © 2025, the Author(s). This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. | en |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0 | |
| dc.source | Batch upload | en |
| dc.subject | MDMA | en |
| dc.subject | PTSD | en |
| dc.subject | Post-traumatic stress disorder | en |
| dc.subject | Psychotherapy | en |
| dc.subject | Treatment-resistant | en |
| dc.subject | Efficacy | en |
| dc.title | Evaluating the efficacy and safety of MDMA for the treatment of Post Traumatic Stress Disorder: a systematic review | en |
| dc.type | Article (peer-reviewed) | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Evaluating+the+efficacy+and+safety+of+MDMA+for+the+treatment+of+Post-Traumatic+Stress+Disorder_+a+systematic+review.pdf
- Size:
- 1.82 MB
- Format:
- Adobe Portable Document Format
- Description:
- Published Version
